December 19, 2023 HER2 and HLA-A*02 Dual CAR-T Cells Utilize LOH in a NOT Logic Gate to Address On-Target Off-Tumor Toxicity
November 4, 2023 Enhancing TCR-T Responses and Overcoming the Tumor Microenvironment in Combination with a TGFβ-specific CAR
August 31, 2023 Manufacturing of CD19/CD20 Bispecific CAR-T Cell Therapy (IMPT-514) for the Treatment of Systemic Lupus Erythematosus
November 16, 2022 Next generation CAR-T incorporating an inhibitory CAR (iCAR) for increased safety in solid tumors
April 12, 2022 Dual CAR T cells selectively target HER2-expressing tumor cells with HLA loss of heterozygosity
